ArticleCureus2025
Empowering the Patient Voice and Optimizing HIV Care in the Middle East.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The Middle East is in a critical phase of its regional human immunodeficiency virus (HIV) response. Infections continue to rise at an alarming rate, and there are significant challenges that hinder the delivery of effective HIV care, such as stigma, lack of awareness, and inadequate access to prevention, testing, and management services. Stigma and discrimination against people living with HIV are pervasive and exacerbated by misinformation. This often impedes linkage to care, thereby promoting the spread of the virus and leading to worsened public health outcomes. There is an urgent need to elevate the patient voice in the context of HIV care in the region, to humanize the epidemic and combat stigma and misinformation. Additionally, the role of patient advocacy groups in the region should be expanded, and various stakeholders, including policymakers and healthcare authorities, should be engaged to optimize the HIV care pathway. We present 15 recommendations aimed at different stakeholders to help achieve these crucial objectives.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.